medroxyprogesterone has been researched along with HPV Infection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balogh, KK; Brendle, SA; Christensen, ND; Cladel, NM; Cooper, T; Hu, J; Li, JJ; Shearer, DA; Walter, V | 1 |
1 other study(ies) available for medroxyprogesterone and HPV Infection
| Article | Year |
|---|---|
Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model.
Topics: Animals; Contraceptive Agents; Disease Models, Animal; Disease Progression; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Papillomavirus Infections | 2022 |